Loading clinical trials...
Loading clinical trials...
A Placebo-controlled, Randomized, Double-blind Study in COvid-19 Patients With iveRmectin; An inVEstigator iniTiaTEd Trial
Conditions
Interventions
Ivermectin 3 MG
Placebo
Locations
1
Japan
Kitasato University
Sagamihara, Kanagawa, Japan
Start Date
September 16, 2020
Primary Completion Date
October 22, 2021
Completion Date
May 31, 2022
Last Updated
January 20, 2022
NCT04525716
NCT03188796
NCT06355232
NCT05191420
NCT04611243
NCT04678193
Lead Sponsor
Kitasato University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions